UPDATED: Managing Excess Treatment Costs in Non-Commercial Research Outcome of the National Consultation
Date: 29 September 2018
Managing Excess Treatment Costs in Non-Commercial Research Outcome of the National Consultation
After a national consultation exercise there will be a new system for the management of Excess Treatment Costs for non-commercial research in England.
This new system will start as a trial period from October 1st 2018 with full roll out by April 2019.
To help us understand these new plans, members of the Forum have written a briefing note with partners from the HRA & NIHR CRN CC.
Please be aware that some elements of the new system are still in development and you can therefore keep yourselves up to date by following our Forum News, HRA_Latest and monitoring our Twitter feeds and the dedicated NIHR CRN webpage here
The following point of clarification has been made to the briefing note
The new arrangements for completing a SoECAT at application stage will apply to:
New calls for single stage applications issued after 1st October 2018
Invitations to submit the second and final stage of an application where the invitation is issued after 1st October 2018 (the call for the first stage application may have been issued prior to 1st October)
NIHR Website Supporting research in the NHS – simplifying research arrangements to improve patient care.
The website includes a route map of the process for the management of ETCs.
If you have any questions about the new processes you can email them into info@rdforum.org.uk and we will collate and forward them on to policy makers.
Please read and share this note with your colleagues so that we are all aware of the changes coming soon.
You can read the briefing note Final version 1.1 updated 26th September here.
National Directive on Commercial Contract Research Studies to come into force from 1st October.
Revisions to the NHS Standard Contract as outlined in the NHS England consultation response will come into force on 1 October. Details of the requirements that providers in England, and therefore commercial companies, will subsequently need to adhere to for commercial contract research are set out in the National Directive
The National Directive on Commercial Contract Research Studies Click Here sets out the requirements providers will need to adhere to for commercial contract research from 1st October. It has been jointly developed by NHS England, HRA and NIHR and:
- Mandates the use of an unmodified model site agreement from 1 October 2018
- Mandates the use of the standard costing methodology (the NIHR Industry Costing Template) from 1 October 2018
- Introduces the concept of a single contract review process which will be further developed for future implementation.
The NHS R&D Forum working groups are collating any feedback from the research management community on this new process so please send any comments to info@rdforum.org.uk
Further information on the process can be found on the NIHR website here Click Here